FDA Accuses Opioid Distributor of Shipping Illegitimate Products

On Tuesday, the FDA continued its investigation and crackdown on bad actors within the pharmaceutical industry by sending a warning letter sent to drug distributor McKessson. The sternly-worded letter accuses the opioid distrubitor of shipping "illegitimate" product. This is the first time the FDA has taken formal enforcement action to curb abuse. The letter from